NeuroPace Share Holder Equity 2020-2024 | NPCE

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

NeuroPace share holder equity from 2020 to 2024. Share holder equity can be defined as the sum of preferred and common equity items

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

NeuroPace share holder equity from 2020 to 2024. Share holder equity can be defined as the sum of preferred and common equity items

Related Stocks
Company Name	Market Cap
Thermo Fisher Scientific (TMO)	$211B
Intuitive Surgical (ISRG)	$191.1B
Alcon (ALC)	$45.7B
IQVIA Holdings (IQV)	$39.8B
Edwards Lifesciences (EW)	$39.1B
IDEXX Laboratories (IDXX)	$35.5B
DexCom (DXCM)	$27.3B
Waters (WAT)	$22.8B
SONOVA HOLDING (SONVY)	$22.1B
STERIS (STE)	$21.6B
Hologic (HOLX)	$18.3B
Sysmex ADR (SSMXY)	$12.9B
Fresenius Medical Care AG KGaA (FMS)	$12.5B
Globus Medical (GMED)	$11B
Teleflex (TFX)	$9.1B
Penumbra (PEN)	$9.1B
Masimo (MASI)	$8.7B
Glaukos (GKOS)	$7.8B
PROCEPT BioRobotics (PRCT)	$5.2B
Integer Holdings (ITGR)	$4.6B
Inari Medical (NARI)	$3B
TransMedics (TMDX)	$2.9B
LivaNova (LIVN)	$2.8B
Veracyte (VCYT)	$2.8B
Nihon Kohden (NHNKY)	$2.6B
Elekta AB (EKTAY)	$2.3B
Tandem Diabetes Care (TNDM)	$2B
Integra LifeSciences Holdings (IART)	$1.9B
RxSight (RXST)	$1.8B
Alphatec Holdings (ATEC)	$1.3B